{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:57:02Z","timestamp":1778605022352,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan"},{"name":"Grants-in-Aid from the Japan Agency for Medical Research and Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10557-020-06987-x","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:04:03Z","timestamp":1589274243000},"page":"535-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Artificial Intelligence Uncovered Clinical Factors for Cardiovascular Events in Myocardial Infarction Patients with Glucose Intolerance"],"prefix":"10.1007","volume":"34","author":[{"given":"Kazuhiro","family":"Shindo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Hitsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyoong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Washio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5157-4213","authenticated-orcid":false,"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"20 Suppl 4","key":"6987_CR1","first-page":"Iv14","volume":"102","author":"E Braunwald","year":"2000","unstructured":"Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000;102(20 Suppl 4):Iv14\u201323.","journal-title":"Circulation"},{"issue":"12","key":"6987_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123\u201333. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.053.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6987_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/nejm199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229\u201334. https:\/\/doi.org\/10.1056\/nejm199807233390404.","journal-title":"N Engl J Med"},{"issue":"4","key":"6987_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10557-017-6740-3","volume":"31","author":"M Asakura","year":"2017","unstructured":"Asakura M, Kim J, Asanuma H, Hamasaki T, Tsukahara K, Higashino Y, et al. Does Treatment of impaired glucose tolerance improve cardiovascular outcomes in patients with previous myocardial infarction? Cardiovasc Drugs Ther. 2017;31(4):401\u201311. https:\/\/doi.org\/10.1007\/s10557-017-6740-3.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6987_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.eclinm.2018.09.006","volume":"4-5","author":"M Asakura","year":"2018","unstructured":"Asakura M, Kim J, Asanuma H, Nakama Y, Tsukahara K, Higashino Y, et al. Cardiovascular outcomes in patients with previous myocardial infarction and mild diabetes mellitus following treatment with pioglitazone: reports of a randomised trial from the Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study). EClinicalMedicine. 2018;4-5:10\u201324. https:\/\/doi.org\/10.1016\/j.eclinm.2018.09.006.","journal-title":"EClinicalMedicine"},{"issue":"32","key":"6987_CR6","doi-asserted-by":"publisher","first-page":"12996","DOI":"10.1073\/pnas.1302233110","volume":"110","author":"A Terada","year":"2013","unstructured":"Terada A, Okada-Hatakeyama M, Tsuda K, Sese J. Statistical significance of combinatorial regulations. Proc Natl Acad Sci U S A. 2013;110(32):12996\u20133001. https:\/\/doi.org\/10.1073\/pnas.1302233110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6987_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ebiom.2018.06.001","volume":"33","author":"H Fukuda","year":"2018","unstructured":"Fukuda H, Shindo K, Sakamoto M, Ide T, Kinugawa S, Fukushima A, et al. Elucidation of the strongest predictors of cardiovascular events in patients with heart failure. EBioMedicine. 2018;33:185\u201395. https:\/\/doi.org\/10.1016\/j.ebiom.2018.06.001.","journal-title":"EBioMedicine."},{"key":"6987_CR8","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.metabol.2017.01.011","volume":"69s","author":"P Hamet","year":"2017","unstructured":"Hamet P, Tremblay J. Artificial intelligence in medicine. Metab Clin Exp. 2017;69s:S36\u2013s40. https:\/\/doi.org\/10.1016\/j.metabol.2017.01.011.","journal-title":"Metab Clin Exp"},{"issue":"1","key":"6987_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10557-019-06922-9","volume":"34","author":"K Shindo","year":"2020","unstructured":"Shindo K, Fukuda H, Hitsumoto T, Ito S, Kim J, Washio T, et al. Plasma BNP levels and diuretics use as predictors of cardiovascular events in patients with myocardial infarction and impaired glucose tolerance. Cardiovasc Drugs Ther. 2020;34(1):79\u201388. https:\/\/doi.org\/10.1007\/s10557-019-06922-9.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"25","key":"6987_CR10","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1161\/circulationaha.106.655761","volume":"114","author":"VJ Dzau","year":"2006","unstructured":"Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation. 2006;114(25):2871\u201391. https:\/\/doi.org\/10.1161\/circulationaha.106.655761.","journal-title":"Circulation."},{"issue":"5","key":"6987_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/bf00400728","volume":"38","author":"Y Yamasaki","year":"1995","unstructured":"Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M, et al. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia. 1995;38(5):585\u201391. https:\/\/doi.org\/10.1007\/bf00400728.","journal-title":"Diabetologia."},{"issue":"9324","key":"6987_CR12","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/s0140-6736(02)09089-x","volume":"359","author":"A Norhammar","year":"2002","unstructured":"Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet (London, England). 2002;359(9324):2140\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(02)09089-x.","journal-title":"Lancet (London, England)"},{"issue":"9638","key":"6987_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/s0140-6736(08)61237-4","volume":"372","author":"HD White","year":"2008","unstructured":"White HD, Chew DP. Acute myocardial infarction. Lancet (London, England). 2008;372(9638):570\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(08)61237-4.","journal-title":"Lancet (London, England)"},{"issue":"24","key":"6987_CR14","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44\u2013e164. https:\/\/doi.org\/10.1016\/j.jacc.2012.07.013.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"6987_CR15","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nm1102-1257","volume":"8","author":"P Libby","year":"2002","unstructured":"Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8(11):1257\u201362. https:\/\/doi.org\/10.1038\/nm1102-1257.","journal-title":"Nat Med"},{"issue":"5","key":"6987_CR16","first-page":"887","volume":"68","author":"M Asakura","year":"2010","unstructured":"Asakura M, Kim J, Asanuma H, Kitakaze M. Anti-diabetic drugs for secondary prevention of cardiovascular disease in mild diabetic and IGT patients: ABC study and PPAR study. Nihon Rinsho Jpn J Clin Med. 2010;68(5):887\u201391.","journal-title":"Nihon Rinsho Jpn J Clin Med"},{"issue":"2","key":"6987_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129\u201346.","journal-title":"Diabetologia."},{"issue":"10","key":"6987_CR18","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1161\/01.Atv.0000239569.99126.37","volume":"26","author":"M Fujita","year":"2006","unstructured":"Fujita M, Okuda H, Tsukamoto O, Asano Y, Hirata YL, Kim J, et al. Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26(10):e138\u201342. https:\/\/doi.org\/10.1161\/01.Atv.0000239569.99126.37.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"6987_CR19","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1161\/hc4601.099485","volume":"104","author":"T Heitzer","year":"2001","unstructured":"Heitzer T, Schlinzig T, Krohn K, Meinertz T, M\u00fcnzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2673\u20138.","journal-title":"Circulation."},{"issue":"8","key":"6987_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/circulationaha.113.003602","volume":"128","author":"YT Ghebremariam","year":"2013","unstructured":"Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, et al. Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation. 2013;128(8):845\u201353. https:\/\/doi.org\/10.1161\/circulationaha.113.003602.","journal-title":"Circulation."},{"issue":"8","key":"6987_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/circulationaha.111.032912","volume":"125","author":"SG Goodman","year":"2012","unstructured":"Goodman SG, Clare R, Pieper KS, Nicolau JC, Storey RF, Cantor WJ, et al. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial. Circulation. 2012;125(8):978\u201386. https:\/\/doi.org\/10.1161\/circulationaha.111.032912.","journal-title":"Circulation."},{"issue":"1","key":"6987_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1253\/circj.71.20","volume":"71","author":"Y Nakamura","year":"2007","unstructured":"Nakamura Y, Saitoh S, Takagi S, Ohnishi H, Chiba Y, Kato N, et al. Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease. Circ J : official journal of the Japanese Circulation Society. 2007;71(1):20\u20135. https:\/\/doi.org\/10.1253\/circj.71.20.","journal-title":"Circ J : official journal of the Japanese Circulation Society"},{"issue":"1","key":"6987_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1440-1681.1995.tb01918.x","volume":"22","author":"Y Ogawa","year":"1995","unstructured":"Ogawa Y, Itoh H, Nakao K. Molecular biology and biochemistry of natriuretic peptide family. Clin Exp Pharmacol Physiol. 1995;22(1):49\u201353.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"11","key":"6987_CR24","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/01.CIR.93.11.1963","volume":"93","author":"T Omland","year":"1996","unstructured":"Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996;93(11):1963\u20139.","journal-title":"Circulation."},{"issue":"2","key":"6987_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jacc.2004.04.033","volume":"44","author":"JL Mega","year":"2004","unstructured":"Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol. 2004;44(2):335\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2004.04.033.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6987_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/A:1016409317640","volume":"26","author":"V Podgorelec","year":"2002","unstructured":"Podgorelec V, Kokol P, Stiglic B, Rozman I. Decision trees: an overview and their use in medicine. J Med Syst. 2002;26(5):445\u201363.","journal-title":"J Med Syst"},{"issue":"6","key":"6987_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10557-004-6226-y","volume":"18","author":"J Kim","year":"2004","unstructured":"Kim J, Washio T, Yamagishi M, Yasumura Y, Nakatani S, Hashimura K, et al. A novel data mining approach to the identification of effective drugs or combinations for targeted endpoints--application to chronic heart failure as a new form of evidence-based medicine. Cardiovasc Drugs Ther. 2004;18(6):483\u20139. https:\/\/doi.org\/10.1007\/s10557-004-6226-y.","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-06987-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:27:57Z","timestamp":1620779277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-06987-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["6987"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-06987-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"12 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No relationship to industry for K.S., H.F, Y.M., J.K., S.I, and T.W. MK reports grants from the Japanese government, grants from Japan Heart Foundation, grants from Japan Agency for Medical Research and Development, personal fees from Daiichi-Sankyo, personal fees from Pfizer, grants and personal fees from Ono, personal fees from Bayer, grants and personal fees from Novartis, grants and personal fees from Boehringer, grants and personal fees from Tanabe-Mitsubishi, personal fees from Japan Medical Data Center, grants and personal fees from Takeda, and grants and personal fees from Astra Zeneca, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}